To get the latest updates about WORLDBI
AND YES! We hate spam too!!
Click here to navigate where you left last time
is a recognized leader at the forefront of innovation in clinical research and medicine development. He is an advisor to technology and biopharmaceutical companies, leading universities, and the venture community, bringing vision and driving action at the intersection of research, digital solutions, and patient engagement.
He currently serves on the Board of Directors for the Foundation for Sarcoidosis Research and the MedStar Health Research Institute, and, as well as on the Editorial Board for Therapeutic Innovation & Regulatory Science. Craig is an Adjunct Assistant Professor in Health Informatics at Rutgers University.
Craig has received the red jacket 'hall of fame' recognition among the PharmaVOICE most inspiring people in the life sciences. He has been recognized among Pharmaceutical Executive’s Emerging Leaders, CenterWatch Top 20 Innovators in Clinical Trials, the Medicine Maker Power List and the AlleyWatch Who's Who in eHealth. He studied Music at Brandeis University and earned a Master of Public Health from Columbia.
Rasmus Hogreffe, MSc.Med., MBA is the Head of Virtual Clinical Trials at LEO Innovation Lab. His main goal is to improve treatment for patients, by making trials better and faster than ever before, using digital and remote innovations.
He holds an Executive MBA and a Master in Medical Science (MSc. Medicine) and has, since 2010, been working in the healthcare industry in various positions within clinical research & development.
Rasmus has extensive experience in the pharmaceutical industry and has been involved in more than 60 clinical trials, giving him a broad knowledge regarding every aspect of clinical research.
Furthermore, Rasmus is a serial entrepreneur and has a successful record of starting and selling companies within his broad scope of interests: Digitalization of clinical trials, Patient recruitment, Real World Data, and Health innovation.
is a physician working in clinical research for past 15 years and is passionate about designing efficient and ethical clinical studies. Prasanna serves as AVP, Global Clinical Sciences, Mylan and is responsible for the clinical strategy and development. He was previously associated with Biocon and Dr Reddy’s. With around 12 years of industry experience, he has led the clinical development of novel biologics, differentiated generics and biosimilars across different therapy areas.
After 4 years working in a Pharmacy, in 2010 Roberto moved to the Clinical Research environment changing different roles.
He started first as CRA and then Project Manager in a Local CRO where he stayed for 4 years, then he moved to Novartis Oncology as Study Manager and then as Head of Study Managers for another 4 years. In the first 8 years of his career he worked in Oncology/_Haematology area.
In the beginning of 2018 Roberto moved to GSK Vaccines where he had the role of Clinical Operations Head
In the beginning of 2020 took the role of Head of Clinical Operations in GSK Pharma (Oncology, Hematology, Respiratory, CardioVascular Disease, Infective Disease)
His hobbies are travelling and sport; He is a sport blogger
Is an experienced strategic leader in global clinical development, line manager of global teams driving & steering change management, globalization, digitalization.
Her experience includes:
Driver of global strategic initiatives & implementation of a global IT- project.
General & operational management of clinical trials & programs based on European & international standards in diverse therapeutic areas.
M & A expertise, Keynote Speaker.
Entrepreneurial leadership style with clear goal orientation
is the Executive Director of the Good Clinical Practice Alliance – Europe (GCPA) in Brussels, Belgium. He is the founder and Director of the Strategic Initiative for Developing Capacity in Ethical Review (SIDCER). He coordinates the GCPA-SIDCER European Fellowship in Research Ethics (EFRE) He is a philosopher specialized in ethical, legal, and regulatory issues in health research, having taught at several European, Asian, and Middle East universities. He is the past Secretary General, Ethics Officer, and Chairman of the Ethics Working Party at the European Forum for Good Clinical Practice. He currently chairs the methodologies sub-group of the Real Word Data Working Group at the Faculty of Pharmaceutical Medicine, Royal Colleges of Physicians. He has acted as an author or expert for the leading international and European research ethics and GCP guidelines, as well as for several guidelines in Asia, Africa, the Americas, and Europe
is a Business Development Officer for the NIHR Clinical Research Network (CRN). Gareth facilitates key discussions between industry and the Clinical Research Network, and is a point of contact for life sciences companies engaging with the Clinical Research Network’s Study Support Service to ensure clinical studies are set up efficiently, and recruit to time and target.
Gareth has been with the Clinical Research Network since 2009. Before joining the Business Development and Marketing Team, Gareth previously worked within the Research Delivery Directorate. He was responsible for supporting interactions between the life sciences industry and the NIHR National Specialty Groups across 7 therapeutic areas, providing operational support through feasibility, set-up and patient recruitment.
loves to delegate; So, 14 years ago when she was offered the job of Clinical Study Manager at a pharmaceutical company with 100% clinical trials outsourcing model, she jumped at the opportunity. In doing so, she left behind her role as Clinical Research Manager at the Technical University of Munich, where she coordinated industry-sponsored trials in radiology and nuclear medicine. Today, Denise heads up a Global Clinical Operations department, where she is dedicated to establishing the best model of outsourcing for the delivery of succinct and successful clinical trials, that meets company culture, conditions and cash-flow. Denise’s degree in Occupational Therapy and professional experience in psychiatry, has taught her that the key to success is not knowing all of the answers but rather good foresight, instincts and most importantly listening.
Is a Financial Business at Norgine Pharmaceuticals since September 2014. She has a background in software development and has over 20 years’ experience as an analyst/developer in JDE/E1.
In 2016 she became a Patient Ambassador for Blood Cancer UK, working with the charity to raise awareness of blood cancers and support efforts to raise funds for life saving treatments. Her role includes speaking at public events, telling her story of diagnosis and treatment, and how her life and the lives of her family have been affected by blood cancer.
Since 2017 she has been a patient representative on the AML trials working group and also patient representative on a number of clinical trials, including AML 18, AML 19 and VICTOR. Jane is a member of the Blood Cancer UK Policy Panel, established in 2019 to make sure people affected by blood cancer are at the very center of Government and NHS decision making. In 2020, she was winner in the Blood Cancer UK 'Most Influential Speaker' category at the Blood Cancer UK Supporter awards.
Tiphaines’ 15+ year experience in product development and clinical trials provides her with a thorough understanding of strategy behind healthcare.
She was able to build a robust business acumen in clinical trials strategy and develop her skills in operational excellence, business improvement and budget negotiation in the pharma industry.
Challenge-driven person, she enjoys leading teams toward over-target performances, in a role where she can contribute to identifying and securing breakthrough innovation and bringing it to patients. Keen on connecting and leading teams, with her recognized problem-solving attitude and analytical mindset, she is passionate about developing her career in transversal roles within Product Development.